Ignite Creation Date:
2024-05-06 @ 4:12 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04901741
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2021-05-20
Brief Title:
Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or GemcitabineNab-Paclitaxel in MSS Pancreatic Cancer
Sponsor:
TME Pharma AG
Organization:
TME Pharma AG
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Pancreatic Cancer |
Keywords: